KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 92 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $41,701,000 | +16.2% | 556,157 | +16.7% | 0.01% | +16.7% |
| Q2 2015 | $35,900,000 | +9.2% | 476,702 | -27.3% | 0.01% | +20.0% |
| Q1 2015 | $32,867,000 | +290.9% | 655,373 | +170.3% | 0.01% | +400.0% |
| Q4 2014 | $8,407,000 | +38.1% | 242,425 | +30.5% | 0.00% | 0.0% |
| Q3 2014 | $6,088,000 | -20.0% | 185,835 | -6.3% | 0.00% | 0.0% |
| Q2 2014 | $7,608,000 | +32.2% | 198,290 | +37.0% | 0.00% | 0.0% |
| Q1 2014 | $5,757,000 | +9.9% | 144,783 | +3.2% | 0.00% | 0.0% |
| Q4 2013 | $5,240,000 | -5.6% | 140,300 | +15.2% | 0.00% | 0.0% |
| Q3 2013 | $5,551,000 | +72.3% | 121,771 | +2.2% | 0.00% | 0.0% |
| Q2 2013 | $3,222,000 | – | 119,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,810,518 | $71,986,000 | 2.98% |
| Redmile Group, LLC | 443,326 | $17,627,000 | 2.10% |
| AlpInvest Partners B.V. | 22,224 | $884,000 | 2.04% |
| SENZAR ASSET MANAGEMENT, LLC | 89,500 | $3,558,000 | 1.88% |
| Aureus Asset Management, LLC | 136,305 | $5,419,000 | 1.39% |
| PFM Health Sciences, LP | 1,003,492 | $39,899,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $7,016,000 | 0.68% |
| Ghost Tree Capital, LLC | 25,000 | $994,000 | 0.59% |
| HAMILTON LANE ADVISORS LLC | 30,264 | $1,203,000 | 0.48% |
| Pentwater Capital Management LP | 390,000 | $15,506,000 | 0.41% |